221 related articles for article (PubMed ID: 2861152)
1. Effect of long-term therapy with sulphasalazine, levamisole, corticosteroids and ascorbic acid and of disease activity on polymorphonuclear leukocyte function in patients with ulcerative colitis.
Hermanowicz A; Sliwiński Z; Kaczor R
Hepatogastroenterology; 1985 Apr; 32(2):81-6. PubMed ID: 2861152
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the chemotactic response of bovine polymorphonuclear leukocytes by levamisole.
Jayappa HG; Loken KI
Am J Vet Res; 1982 Dec; 43(12):2138-42. PubMed ID: 6762119
[TBL] [Abstract][Full Text] [Related]
3. [Fatal granulocyte function defect in a male infant. Results of in vitro and in vivo stimulation with ascorbic acid as well as in vitro stimulation with levamisol and lithium chloride].
Dopfer R; Döring A; Neef V; Kollmann W; Niethammer D
Monatsschr Kinderheilkd; 1982 Dec; 130(12):891-5. PubMed ID: 6296667
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil dysfunction and repeated infections: influence of levamisole and ascorbic acid.
Rebora A; Dallegri F; Patrone F
Br J Dermatol; 1980 Jan; 102(1):49-56. PubMed ID: 7378281
[TBL] [Abstract][Full Text] [Related]
5. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
[TBL] [Abstract][Full Text] [Related]
6. Chemotactic function of polymorphonuclear leukocytes from patients with recurrent infections: partial correction by levamisole "in vitro".
Stein AN; Díez RA; Sen L; Estévez ME
Allergol Immunopathol (Madr); 1985; 13(2):127-34. PubMed ID: 4003229
[TBL] [Abstract][Full Text] [Related]
7. Controlled therapeutic trial of levamisole and sulphasalazine in acute ulcerative colitis.
Hermanowicz A; Nowak A; Gajos L
Gut; 1984 May; 25(5):S34-8. PubMed ID: 6143709
[TBL] [Abstract][Full Text] [Related]
8. Effects of levamisole on normal and abnormal leukocyte locomotion.
Wright DG; Kirkpatrick CH; Gallin JI
J Clin Invest; 1977 May; 59(5):941-50. PubMed ID: 192765
[TBL] [Abstract][Full Text] [Related]
9. IgA-related defective neutrophil chemotaxis in ulcerative colitis.
Patrone F; Dallegri F; Sacchetti C
Boll Ist Sieroter Milan; 1978 May; 57(2):204-7. PubMed ID: 31895
[TBL] [Abstract][Full Text] [Related]
10. Function of polymorphonuclear neutrophilic leucocytes. Comparison of leucocytes from blood and exudate in healthy volunteers.
Wandall JH
Acta Pathol Microbiol Immunol Scand C; 1982 Feb; 90(1):7-13. PubMed ID: 7044042
[TBL] [Abstract][Full Text] [Related]
11. Defective neutrophil motility and recurrent infection. In vitro and in vivo effects of levamisole.
Rabson AR; Anderson R; Glover A
Clin Exp Immunol; 1978 Jul; 33(1):142-9. PubMed ID: 709909
[TBL] [Abstract][Full Text] [Related]
12. Relationship between adherence, chemotaxis and the accumulation of rat polymorphonuclear leukocytes at an inflammatory site.
Ackerman N; Martinez S; Thieme T; Mirkovich A
J Pharmacol Exp Ther; 1982 Jun; 221(3):701-7. PubMed ID: 7086682
[TBL] [Abstract][Full Text] [Related]
13. The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis.
Molin L; Stendahl O
Acta Med Scand; 1979; 206(6):451-7. PubMed ID: 43662
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulating influence of levamisole on migration of leukocytes in vivo and in vitro in patients treated for a long time with corticosteroids.
Matusiewicz R; Wiśniewski J; Sliwiński J
Arch Immunol Ther Exp (Warsz); 1985; 33(6):763-7. PubMed ID: 3833117
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of human PMNs in vitro by a succinimide molecular complex of methylfurylbutyrolactone.
Woolverton CJ; Veltri RW; Snyder IS
J Biol Response Mod; 1986 Dec; 5(6):527-38. PubMed ID: 3540219
[TBL] [Abstract][Full Text] [Related]
16. Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study.
Nilsson A; Danielsson A; Löfberg R; Benno P; Bergman L; Fausa O; Florholmen J; Karvonen AL; Kildebo S; Kollberg B
Am J Gastroenterol; 1995 Mar; 90(3):381-7. PubMed ID: 7872274
[TBL] [Abstract][Full Text] [Related]
17. Nitroblue tetrazolium test in course of ulcerative colitis.
Zagórski K; Prokopowicz D
Rocz Akad Med Bialymst; 1997; 42(1):69-74. PubMed ID: 9581465
[TBL] [Abstract][Full Text] [Related]
18. Correction of corticosteroid-induced defects of polymorphonuclear neutrophil function by ascorbic acid.
Chretien JH; Garagusi VF
J Reticuloendothel Soc; 1973 Sep; 14(3):280-6. PubMed ID: 4745531
[No Abstract] [Full Text] [Related]
19. Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial.
Musch E; Andus T; Malek M; Chrissafidou A; Schulz M
Z Gastroenterol; 2007 Dec; 45(12):1235-40. PubMed ID: 18080224
[TBL] [Abstract][Full Text] [Related]
20. [Immunosuppressive therapy in ulcerative rectocolitis. Long-term assessment of results].
Aresu G; Mereu S; Frongia N; Casula G; Uccheddu A
Minerva Med; 1982 Apr; 73(14):767-86. PubMed ID: 6122191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
